Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
Beijing and Shanghai, China, Aug 17, 2020 – (ACN Newswire) – Bayer and Hua Medicine,…
Lithosphere Deploys MultX to Enable Atomic Cross-Chain Execution on Makalu
American Aires Inc. Announces Change of Auditor
Zhibao Technology Announces 1H2026 Earnings Conference Call and Investor Webinar Participation
Integrated Quantum Technologies Announces Non-Brokered Private Placement of Units
TechCon Global Announces Dr. Irwin Jacobs as Recipient of the TechCon Fellows Lifetime Achievement Award